z-logo
Premium
Therapeutic Efficacy of Basic Fibroblast Growth Factor in Patients With Vocal Fold Atrophy
Author(s) -
Okui Ayako,
Konomi Ujimoto,
Kanazawa Takeharu,
Komazawa Daigo,
Nakamura Kazuhiro,
Matsushima Koji,
Watanabe Yusuke
Publication year - 2020
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.28541
Subject(s) - atrophy , medicine , basic fibroblast growth factor , phonation , vocal folds , laryngology , audiology , growth factor , larynx , surgery , urology , receptor
Objectives/Hypothesis In recent years, basic fibroblast growth factor (bFGF) injection has been used in the treatment of aging‐related vocal fold atrophy. This injection not only improves closure by increasing the mass of the vocal fold but also improves its viscoelasticity. However, it has been reported that fibroblasts targeted by bFGF treatment decrease in number with age. The purpose of this study was to examine the effects of local injection of bFGF on age‐related vocal atrophy as well as the influence of age on phonological outcomes. Study Design Retrospective chart review. Methods Fifty‐three patients with age‐related vocal fold atrophy underwent single injections of bFGF in their vocal folds. Phonological outcomes were evaluated 3 and 6 months after injection by acoustic and aerodynamic measurements. Results Voice Handicap Index (VHI), maximum phonation time (MPT), jitter, shimmer, and pitch range improved after injection, and the effects continued for 6 months. In those over 70 years of age, VHI and MPT showed improvement at 3 and 6 months after injection. In addition, the degree of improvement in VHI and MPT did not differ significantly between those older than 70 years and those younger than 70 years. Conclusions Regenerative treatments dependent on bFGF single injection was safe and effective for both early and late elderly patients suffering of vocal fold atrophy. Level of Evidence 2c Laryngoscope , 2020

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here